ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.
Stopping aspirin after 1 month DAPT in ACS patients after stent placement
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Stopping aspirin after 1 month DAPT in ACS patients after stenting
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Gregg Stone, MD is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 8 april 2024
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Gregg Stone, MD is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 8 april 2024
Presenters
Facebook Comments